venBio Partners LLC Long-Term Concentrated

CIK: 0001776382 · Show all filings

Period: Q4 2025 (← Previous)

Filing Date: Feb 17, 2026

Total Value ($000): $216,273 (100.0% shares, 0.0% debt)

Holdings (6)

Decreased Positions (2)

LYEL LYELL IMMUNOPHARMA INC 4.8%

Value ($000) $10,394 (+35.2%) Shares 337,697 (-28.7%) Est. Cost $9.11 Unrealized +145.6%

ARTV ARTIVA BIOTHERAPEUTICS INC 1.3%

Value ($000) $2,782 (-15.6%) Shares 648,507 (-43.6%) Est. Cost $11.59 Unrealized -67.4%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
LYEL	LYELL IMMUNOPHARMA INC	337,697 (-28.7%)	$10,394 (+35.2%)	4.8%	$9.11	+145.6%	COM NEW	55083R203
ARTV	ARTIVA BIOTHERAPEUTICS INC	648,507 (-43.6%)	$2,782 (-15.6%)	1.3%	$11.59	-67.4%	COM	04317A107

Unchanged Positions (4)

ALMS ALUMIS INC 20.8%

Value ($000) $45,089 Shares 4,619,803 Est. Cost $9.90 Unrealized -29.5%

PHVS PHARVARIS N V 59.5%

Value ($000) $128,741 Shares 4,639,304 Est. Cost $21.23 Unrealized +13.5%

ALXO ALX ONCOLOGY HLDGS INC 5.1%

Value ($000) $10,961 Shares 9,699,925 Est. Cost $39.31 Unrealized -96.1%

HRMY HARMONY BIOSCIENCES HLDGS IN 8.5%

Value ($000) $18,306 Shares 489,194 Est. Cost $36.46 Unrealized -9.8%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ALMS	ALUMIS INC	4,619,803	$45,089	20.8%	$9.90	-29.5%	COM	022307102
PHVS	PHARVARIS N V	4,639,304	$128,741	59.5%	$21.23	+13.5%	COM	N69605108
ALXO	ALX ONCOLOGY HLDGS INC	9,699,925	$10,961	5.1%	$39.31	-96.1%	COM	00166B105
HRMY	HARMONY BIOSCIENCES HLDGS IN	489,194	$18,306	8.5%	$36.46	-9.8%	COM	413197104